Upgrade to SI Premium - Free Trial

Pfizer (PFE)

42.91 -0.20 (0.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/1/22)
- M&A (N/A)
- M&A (N/A)
- M&A (6/30/20 *Est)
- M&A (3/31/23 *Est)

Latest Headlines

U.S. CDC advisers approve adding COVID shots to vaccine schedules October 20, 2022 3:32 PM - StreetInsider CDC panel votes to add COVID shots to kids' vaccine schedule - DJ October 20, 2022 1:30 PM - StreetInsider Erasca, Inc (ERAS) Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination October 20, 2022 8:00 AM - StreetInsider Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination October 20, 2022 8:00 AM - Globe NewsWire Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination October 20, 2022 8:00 AM - StreetInsider Pfizer (PFE) and BioNTech (BNTX) Receive Positive CHMP Opinion for COMIRNATY in Children 6 Months to less than 5 Years in the European Union October 19, 2022 11:46 AM - StreetInsider Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union October 19, 2022 11:45 AM - StreetInsider EMA Recommends MRNA Covid Vaccines From 4 Months Of Age - Bloomberg October 19, 2022 11:21 AM - StreetInsider Form 4 PFIZER INC For: Oct 14 Filed by: JOHNSON RADY A October 18, 2022 7:12 PM - SEC Filing Form 4 PFIZER INC For: Oct 14 Filed by: BOURLA ALBERT October 18, 2022 7:12 PM - SEC Filing Form 4 PFIZER INC For: Oct 14 Filed by: DAMICO JENNIFER B. October 18, 2022 7:12 PM - SEC Filing Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022 October 18, 2022 12:00 PM - BizWire Form 4 PFIZER INC For: Oct 12 Filed by: DAMICO JENNIFER B. October 13, 2022 6:15 PM - SEC Filing Form 4 PFIZER INC For: Oct 12 Filed by: JOHNSON RADY A October 13, 2022 6:15 PM - SEC Filing Form 4 PFIZER INC For: Oct 12 Filed by: BOURLA ALBERT October 13, 2022 6:15 PM - SEC Filing GSK: Trials for Respiratory Virus Vaccine "Positive" October 13, 2022 7:27 AM - StreetInsider BioNTech SE (BNTX) and Pfizer (PFE) Report Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster October 13, 2022 6:47 AM - StreetInsider Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older October 13, 2022 6:45 AM - BizWire Pfizer and BioNTech Announce Positive Early Data From Clinical Trial of Omicron BA.4/BA.5-Adapted Bivalent Booster in Individuals 18 Years and Older October 13, 2022 6:45 AM - StreetInsider Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age October 12, 2022 10:30 AM - StreetInsider Pfizer (PFE), BioNTech (BNTX) Confirm U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age October 12, 2022 10:16 AM - StreetInsider Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age October 12, 2022 10:16 AM - BizWire U.S. authorizes updated COVID booster shots for children as young as 5 October 12, 2022 9:58 AM - StreetInsider FDA Authorizes Moderna and Pfizer-BioNTech Bivalent COVID-19 Vaccines for Use as a Booster Dose in Younger Age Groups (MRNA) (PFE) (BNTX) October 12, 2022 9:48 AM - StreetInsider Pfizer (PFE) PT Raised to $50 at Morgan Stanley October 12, 2022 6:03 AM - StreetInsider Pfizer (PFE) PT Lowered to $44 at Barclays October 12, 2022 5:50 AM - StreetInsider Pfizer (PFE) PT Lowered to $50 at JPMorgan October 11, 2022 9:11 AM - StreetInsider Pfizer (PFE) PT Lowered to $48 at SVB Leerink on Likely Q3 'Miss' October 11, 2022 7:39 AM - StreetInsider Pfizer (PFE) and BioNTech's (BNTX) Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster Receives Health Canada Authorization for Individuals 12 Years of Age and Older October 7, 2022 11:04 AM - StreetInsider COVID rebound after Pfizer treatment likely due to robust immune response, study finds October 6, 2022 4:45 PM - StreetInsider Pfizer (PFE) Completes Acquisition of Global Blood Therapeutics (GBT) October 5, 2022 9:03 AM - StreetInsider Pfizer Completes Acquisition of Global Blood Therapeutics  October 5, 2022 9:02 AM - BizWire Pfizer COVID vaccine clears Japan panel for use with young children October 5, 2022 6:26 AM - StreetInsider Voyager Therapeutics (VYGR) Announces Pfizer License of Next-Generation AAV Capsid for Rare Neurologic Disease Target October 4, 2022 7:02 AM - StreetInsider Pfizer (PFE) Reports Positive Topline Results from Phase 3 TALAPRO-2 Trial October 4, 2022 6:45 AM - StreetInsider Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial October 4, 2022 6:45 AM - BizWire Form 4 PFIZER INC For: Sep 30 Filed by: SMITH JAMES C October 3, 2022 7:09 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: Quincey James October 3, 2022 7:09 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: NARAYEN SHANTANU October 3, 2022 7:09 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: Echevarria Joseph October 3, 2022 7:08 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: JOHNSON RADY A October 3, 2022 4:54 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: DAMICO JENNIFER B. October 3, 2022 4:54 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: BOURLA ALBERT October 3, 2022 4:53 PM - SEC Filing Pfizer (PFE) Completes Acquisition of Biohaven Pharmaceuticals October 3, 2022 1:01 PM - StreetInsider Pfizer Completes Acquisition of Biohaven Pharmaceuticals October 3, 2022 1:01 PM - BizWire Biohaven Pharma (BHVN) says closing of acquisition by Pfizer (PFE) is expected to be on October 3 September 27, 2022 5:32 PM - StreetInsider Fitch Revises Pfizer's Outlook to Positive; Affirms IDR at 'A' September 26, 2022 2:29 PM - StreetInsider Pfizer/BioNTech seek FDA nod for new COVID boosters for children September 26, 2022 7:20 AM - StreetInsider BioNTech SE (BNTX) and Pfizer (PFE) Submit FDA Application for EMA of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children Aged 5-11 September 26, 2022 6:45 AM - StreetInsider Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age September 26, 2022 6:45 AM - BizWire Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age September 26, 2022 6:45 AM - StreetInsider U.S. rollout of new COVID boosters off to slow start September 23, 2022 8:47 AM - StreetInsider Pfizer (PFE) Declares $0.40 Quarterly Dividend; 3.6% Yield September 22, 2022 8:03 AM - StreetInsider Pfizer Declares Fourth-Quarter 2022 Dividend September 22, 2022 8:00 AM - BizWire BMO Capital Reiterates Outperform Rating on Pfizer (PFE) as Early-Stage Oral GLP-1s Show Promise in T2D & Obesity September 22, 2022 7:35 AM - StreetInsider Pfizer to Supply Global Fund Up to 6 Million PAXLOVID™ Treatment Courses for Low-and-Middle-Income Countries September 22, 2022 6:45 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of November 1 Conference Call with Analysts September 20, 2022 10:00 AM - BizWire Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in EU September 19, 2022 6:45 AM - StreetInsider Pfizer Announces Positive Top-Line Results from Phase 3 Study in 20-Valent Pneumococcal Conjugate Vaccine in Infants in the European Union September 19, 2022 6:45 AM - BizWire Form 4 PFIZER INC For: Sep 15 Filed by: JOHNSON RADY A September 16, 2022 4:03 PM - SEC Filing Form 4 PFIZER INC For: Sep 15 Filed by: BOURLA ALBERT September 16, 2022 4:03 PM - SEC Filing Form 4 PFIZER INC For: Sep 15 Filed by: DAMICO JENNIFER B. September 16, 2022 4:03 PM - SEC Filing Pfizer (PFE), BioNTech (BNTX) Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union September 16, 2022 8:00 AM - StreetInsider Pfizer and BioNTech Receive Positive CHMP Opinion for Conversion of COMIRNATY® Conditional Marketing Authorization to Full Marketing Authorization in the European Union September 16, 2022 8:00 AM - StreetInsider Pfizer (PFE): Meningococcal Ph3 Vax Data an 'Incremental Positive' - Morgan Stanley September 16, 2022 5:40 AM - StreetInsider Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Trial of MenABCWY September 15, 2022 6:45 AM - StreetInsider Pfizer Announces Positive Top-Line Results from Phase 3 Trial of Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents September 15, 2022 6:45 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of Analyst and Investor Call to Review Oral GLP-1 Data Presented at European Association for the Study of Diabetes (EASD) 2022 September 14, 2022 10:00 AM - BizWire Pfizer (PFE) Initiates Phase 3 Study of mRNA-Based Influenza Vaccine September 14, 2022 6:45 AM - StreetInsider Pfizer Initiates Phase 3 Study of mRNA-Based Influenza Vaccine September 14, 2022 6:45 AM - BizWire Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer September 13, 2022 8:45 AM - PR NewsWire Pfizer (PFE), BioNTech (BNTX) Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union September 12, 2022 11:20 AM - StreetInsider Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union September 12, 2022 11:20 AM - BizWire Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in European Union September 12, 2022 11:20 AM - StreetInsider Health Canada authorizes Pfizer (PFE) -BioNTech (BNTX) COVID-19 vaccine for children six months to four years of age September 9, 2022 11:05 AM - StreetInsider Pfizer (PFE) Announces FDA and EMA Acceptance of Ritlecitinib for Alopecia Areata September 9, 2022 6:47 AM - StreetInsider FDA and EMA Accept Regulatory Submission for Pfizer’s Ritlecitinib for Individuals 12 Years and Older with Alopecia Areata September 9, 2022 6:45 AM - BizWire Pfizer (PFE) Group B Streptococcus Vaccine Candidate Granted FDA Breakthrough Therapy Designation September 7, 2022 6:51 AM - StreetInsider FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women September 7, 2022 6:45 AM - BizWire ICON Releases its 2021 ESG Report September 6, 2022 4:15 PM - BizWire Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference September 6, 2022 11:00 AM - BizWire Pfizer Invites Public to View and Listen to a Webcast of Pfizer Discussion on Climate Action September 6, 2022 10:00 AM - BizWire Pfizer (PFE) Wins CDC Panel Vote On Ba.4/5 Variant Booster - Bloomberg September 1, 2022 5:47 PM - StreetInsider Form 4 PFIZER INC For: Aug 31 Filed by: JOHNSON RADY A September 1, 2022 4:03 PM - SEC Filing Form 4 PFIZER INC For: Aug 31 Filed by: DAMICO JENNIFER B. September 1, 2022 4:02 PM - SEC Filing Form 4 PFIZER INC For: Aug 31 Filed by: BOURLA ALBERT September 1, 2022 4:02 PM - SEC Filing Pfizer Invites Public to View and Listen to Two Webcasts of Pfizer Discussions at Healthcare Conferences September 1, 2022 10:00 AM - BizWire BioNTech SE (BNTX) and Pfizer (PFE) Receive Positive CHMP Opinion for COVID-19 Vaccine Booster in EU September 1, 2022 9:46 AM - StreetInsider Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union September 1, 2022 9:45 AM - BizWire Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.1-Adapted Bivalent COVID-19 Vaccine Booster in European Union September 1, 2022 9:45 AM - StreetInsider Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older August 31, 2022 10:18 AM - BizWire Pfizer (PFE), BioNTech SE (BNTX) Confirm FDA EUA for Omicron Booster August 31, 2022 10:15 AM - StreetInsider Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older August 31, 2022 10:13 AM - StreetInsider FDA okays Moderna (MRNA), Pfizer (PFE) Omicron boosters August 31, 2022 9:55 AM - StreetInsider Moderna (MRNA) Sues Pfizer (PFE) and BioNTech (BNTX) Over Covid Vaccine Technology August 26, 2022 12:45 PM - StreetInsider  Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine August 26, 2022 9:52 AM - BizWire Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent Vaccine August 26, 2022 9:45 AM - StreetInsider Moderna (MRNA) Sues Pfizer (PFE) and BioNTech (BNTX) for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform August 26, 2022 8:02 AM - StreetInsider Pfizer (PFE) Reports Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate August 25, 2022 6:45 AM - StreetInsider Pfizer Announces Positive Top-Line Data from Phase 3 Trial of Older Adults for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate August 25, 2022 6:45 AM - BizWire Pfizer (PFE) and BioNTech (BNTX) Report Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years Old August 23, 2022 6:45 AM - StreetInsider Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age August 23, 2022 6:45 AM - BizWire Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age August 23, 2022 6:45 AM - StreetInsider BioNTech SE (BNTX) and Pfizer (PFE) Submit FDA Application for EMA of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine August 22, 2022 10:31 AM - StreetInsider Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine August 22, 2022 10:30 AM - BizWire Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine August 22, 2022 10:30 AM - StreetInsider Pfizer (PFE) Ordered by FDA to Test Impact of Repeat Course of Paxlovid - BBG August 19, 2022 3:48 PM - StreetInsider Pfizer (PFE) To Study Repeat Paxlovid Regimen At Us FDA Order - Bloomberg August 19, 2022 2:56 PM - StreetInsider Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference August 19, 2022 10:00 AM - BizWire Moderna (MRNA), Pfizer (PFE) on Watch Following Report U.S. Plans for End of Coverage for Covid Shots, Treatments August 18, 2022 12:03 PM - StreetInsider US Plans For End Of Covid-19 Shot, Treatment Coverage - WSJ August 18, 2022 12:01 PM - StreetInsider Form 4 PFIZER INC For: Aug 15 Filed by: JOHNSON RADY A August 16, 2022 3:44 PM - SEC Filing Form 4 PFIZER INC For: Aug 15 Filed by: DAMICO JENNIFER B. August 16, 2022 3:44 PM - SEC Filing Form 4 PFIZER INC For: Aug 15 Filed by: BOURLA ALBERT August 16, 2022 3:44 PM - SEC Filing ProMIS Neurosciences Announces Second Quarter 2022 Financial and Operating Results August 15, 2022 5:00 PM - StreetInsider Pfizer (PFE) Reports Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants August 12, 2022 6:46 AM - StreetInsider Pfizer Announces Positive Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Infants August 12, 2022 6:45 AM - BizWire Pfizer (PFE) option IV near low end of range August 12, 2022 4:26 AM - StreetInsider Stocks expected to have increasing option volume: PBR ILMN HLN GSK SNY PFE August 12, 2022 3:53 AM - StreetInsider NextRNA Therapeutics Names Dominique Verhelle as CEO and Expands Leadership Team August 11, 2022 2:30 PM - BizWire Form 10-Q PFIZER INC For: Jul 03 August 10, 2022 4:28 PM - SEC Filing GLOBAL BLOOD THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GBT and Encourages Investors to Contact the Firm August 9, 2022 4:49 PM - StreetInsider Pfizer (PFE) and Valneva (VALN) Initiate Phase 3 Study of VLA15 August 8, 2022 4:47 PM - StreetInsider Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 August 8, 2022 4:45 PM - BizWire Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 August 8, 2022 4:45 PM - StreetInsider Global Blood Therapeutics (GBT) Shares Tick Higher After Pfizer Buy Agreed August 8, 2022 11:33 AM - StreetInsider Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal August 8, 2022 6:48 AM - StreetInsider Pfizer (PFE) to Acquire Global Blood Therapeutics (GBT) for $5.4 Billion, $68.50 Per Share August 8, 2022 6:46 AM - StreetInsider Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology August 8, 2022 6:45 AM - BizWire Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology August 8, 2022 6:45 AM - Globe NewsWire Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis August 5, 2022 8:50 PM - Globe NewsWire Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis August 5, 2022 8:50 PM - StreetInsider Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks August 5, 2022 11:54 AM - StreetInsider UPDATE: Pfizer (PFE) is in advanced talks to buy Global Blood Therapeutics (GBT) - WSJ August 5, 2022 11:35 AM - StreetInsider Form 4 PFIZER INC For: Jul 29 Filed by: JOHNSON RADY A August 1, 2022 3:42 PM - SEC Filing Form 4 PFIZER INC For: Jul 29 Filed by: DAMICO JENNIFER B. August 1, 2022 3:42 PM - SEC Filing Form 4 PFIZER INC For: Jul 29 Filed by: BOURLA ALBERT August 1, 2022 3:42 PM - SEC Filing Pfizer (PFE) PT Raised to $64 at Truist Securities August 1, 2022 7:11 AM - StreetInsider Pfizer (PFE) PT Raised to $64 at Truist Securities; 'Incrementally more positive' following results July 29, 2022 12:11 PM - StreetInsider ViiV Healthcare presents positive five-year data at AIDS 2022, demonstrating the durability of fostemsavir in people living with HIV who are heavily treatment-experienced July 29, 2022 8:04 AM - BizWire Pfizer (PFE) PT Lowered to $50 at Barclays July 29, 2022 4:36 AM - StreetInsider Popular stocks increasing volume: PFE TWTR AMC SNAP SHOP INTC July 28, 2022 4:13 PM - StreetInsider Pfizer (PFE) Earnings Growth 'Underappreciated' - Cantor Fitzgerald July 28, 2022 1:32 PM - StreetInsider ViiV Healthcare Announces New Data at AIDS 2022 From Unblinded Phase of HPTN 084 Study in Women in Sub-Saharan Africa Showing Continued Superior Efficacy of Injectable Cabotegravir Long-Acting for PrE July 28, 2022 10:05 AM - BizWire ViiV Healthcare and the Medicines Patent Pool Sign New Voluntary Licensing Agreement to Expand Access to Innovative Long-Acting HIV Prevention Medicine July 28, 2022 10:04 AM - BizWire Form 8-K PFIZER INC For: Jul 28 July 28, 2022 8:09 AM - SEC Filing Pfizer leaves COVID product forecast unchanged, shares fall July 28, 2022 6:50 AM - StreetInsider Pfizer (PFE) Tops Q2 EPS by 33c, Reaffirms FY22 Comirnaty and Paxlovid Sales Guidance July 28, 2022 6:46 AM - StreetInsider PFIZER REPORTS SECOND-QUARTER 2022 RESULTS July 28, 2022 6:45 AM - BizWire Pfizer (PFE) calls more active than put into quarter results and outlook July 27, 2022 10:46 AM - StreetInsider BioNTech SE (BNTX) and Pfizer (PFE) Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design July 27, 2022 6:47 AM - StreetInsider Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design July 27, 2022 6:45 AM - StreetInsider Pfizer (PFE) July weekly 52 straddle priced for a move of 4% into quarter results July 27, 2022 5:16 AM - StreetInsider BioNTech, Pfizer sue CureVac in U.S. over COVID-19 vaccine patent claims July 26, 2022 11:59 AM - StreetInsider Pfizer loses U.S. appeal over co-pays for heart failure patients July 25, 2022 11:33 AM - StreetInsider Full Article List